David Larsen
Stock Analyst at BTIG
(2.02)
# 3,173
Out of 5,090 analysts
88
Total ratings
35.62%
Success rate
-3.34%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Reiterates: Buy | $130 | $94.51 | +37.55% | 5 | Dec 4, 2025 | |
| VEEV Veeva Systems | Reiterates: Buy | $340 | $242.00 | +40.50% | 4 | Nov 21, 2025 | |
| LFMD LifeMD | Maintains: Buy | $18 → $10 | $3.50 | +185.71% | 4 | Nov 18, 2025 | |
| EVH Evolent Health | Maintains: Buy | $20 → $16 | $3.94 | +306.09% | 7 | Nov 7, 2025 | |
| ASTH Astrana Health | Maintains: Buy | $50 → $45 | $22.07 | +103.90% | 2 | Nov 7, 2025 | |
| LFST LifeStance Health Group | Maintains: Buy | $8 → $9 | $6.48 | +38.89% | 1 | Nov 6, 2025 | |
| HIMS Hims & Hers Health | Reiterates: Buy | $85 | $39.20 | +116.84% | 2 | Nov 4, 2025 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $30 → $41 | $35.79 | +14.56% | 3 | Oct 29, 2025 | |
| TOI The Oncology Institute | Reiterates: Buy | $7 | $3.03 | +131.02% | 1 | Oct 21, 2025 | |
| CYRX Cryoport | Maintains: Buy | $10 → $15 | $9.54 | +57.23% | 4 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.60 | - | 4 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $25 | $19.64 | +27.29% | 3 | Jul 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $80 | $45.93 | +74.18% | 2 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 | $24.02 | +16.57% | 4 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $31 | $22.41 | +38.33% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $290 → $260 | $225.85 | +15.12% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $2.46 | +184.55% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $1.05 | +566.67% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.24 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $40.50 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.65 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $23.84 | +46.81% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.59 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $4.01 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $198.83 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $808.62 | -80.21% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $73.62 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $75.63 | +12.39% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $2.59 | +788.03% | 1 | Nov 2, 2017 |
HealthEquity
Dec 4, 2025
Reiterates: Buy
Price Target: $130
Current: $94.51
Upside: +37.55%
Veeva Systems
Nov 21, 2025
Reiterates: Buy
Price Target: $340
Current: $242.00
Upside: +40.50%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $18 → $10
Current: $3.50
Upside: +185.71%
Evolent Health
Nov 7, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $3.94
Upside: +306.09%
Astrana Health
Nov 7, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $22.07
Upside: +103.90%
LifeStance Health Group
Nov 6, 2025
Maintains: Buy
Price Target: $8 → $9
Current: $6.48
Upside: +38.89%
Hims & Hers Health
Nov 4, 2025
Reiterates: Buy
Price Target: $85
Current: $39.20
Upside: +116.84%
BrightSpring Health Services
Oct 29, 2025
Maintains: Buy
Price Target: $30 → $41
Current: $35.79
Upside: +14.56%
The Oncology Institute
Oct 21, 2025
Reiterates: Buy
Price Target: $7
Current: $3.03
Upside: +131.02%
Cryoport
Sep 18, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $9.54
Upside: +57.23%
Sep 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.60
Upside: -
Jul 7, 2025
Maintains: Buy
Price Target: $41 → $25
Current: $19.64
Upside: +27.29%
Jun 2, 2025
Upgrades: Buy
Price Target: $80
Current: $45.93
Upside: +74.18%
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $24.02
Upside: +16.57%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $22.41
Upside: +38.33%
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $225.85
Upside: +15.12%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $2.46
Upside: +184.55%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $1.05
Upside: +566.67%
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.24
Upside: -
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $40.50
Upside: -
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $0.65
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $23.84
Upside: +46.81%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $7.59
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $4.01
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $198.83
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $808.62
Upside: -80.21%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $73.62
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $75.63
Upside: +12.39%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $2.59
Upside: +788.03%